Background: Prostaglandin E2 is one of the potential products that promotes development of tumors and also is a strong inducer of M2 phenotype macrophages, which contribute to tumor development in the immunosuppressed microenvironment. Hangeshashinto (TJ-14), a Japanese traditional medicine (Kampo medicine), has been reported to be effective in preventing chemotherapy-induced oral mucositis through the reduction of prostaglandin E2. We previously developed a surgical rat reflux model of esophageal cancer and used this well-established animal model to investigate the action of TJ-14 in preventing esophageal cancer. We also assessed the effect of TJ-14 on the downregulation of prostaglandin E2 production, utilizing esophageal squamous cell carcinoma cell line exposed to bile acid. Methods: An end-to-side esophagojejunostomy was performed for the reflux model. A daily oral diet was subsequently administered, consisting of either diet-incorporated TJ-14 or standard diet as a control group. The rats were killed at 40 weeks after surgery. The incidence of esophageal cancer, Barrett's metaplasia, and proliferative hyperplasia were assessed histologically. CD163, a M2 phenotype macrophage marker, was assessed with immunohistochemistry. Prostaglandin E2 enzyme immunoassay and lactate dehydrogenase assay were performed on chenodeoxycholic acid or gastroesophageal reflux contents exposed to esophageal squamous cell carcinoma cell line. Results: Sixty-seven percent of the controls ( n = 12) developed esophageal cancer, but animals that received TJ-14 ( n = 10) had a cancer incidence of 10% ( P = . 007). Barrett's metaplasia was found in 83% of the rats in the control group and 50% of the rats in the TJ-14 indicating a protective tendency of TJ-14 ( P = . 095). All of the rats developed proliferative hyperplasia. The number of M2 phenotype macrophage were significantly decreased in the TJ-14 group compared to the control group in both Barrett's metaplasia and esophageal cancer lesions. TJ-14 inhibited chenodeoxycholic acid or gastroesophageal reflux content-induced prostaglandin E2 production in esophageal squamous cell carcinoma cell. Conclusion: TJ-14 reduced the incidence of reflux-induced esophageal cancer and the infiltration of M2 macrophages in a surgical rat model or suppressed prostaglandin E2 production in esophageal squamous
Esophageal carcinoma is the sixth leading cause of cancerrelated mortality, and the incidence is rapidly increasing. 1 Esophageal squamous-cell carcinoma (ESCC) is the predominant form of esophageal carcinoma worldwide, but a shift in epidemiology has been seen in several Western countries, where the incidence of esophageal adenocarcinoma (EADC) now exceeds that of squamous-cell types. 2 The incidence rates for EADC of the esophagus have been increasing dramatically in part due to increases in known risk factors (i.e., gastroesophageal reflux disease). 3 Gastroesophageal reflux disease (GERD) has been identified as an important risk factor of both Barrett's metaplasia (BM) and EADC. 4, 5 Our group pioneered the development of animal models for esophageal cancer, surgically creating esophageal reflux leading to the sequential transformation of normal epithelium into metaplastic epithelium, called BM, then to dysplasia, and finally cancer. This model has the distinct advantage of promoting rat esophageal mucosal carcinogenesis without exogenous carcinogens and replicates the clinical progression of disease. Histopathologic analyses of these cancers demonstrate that they resemble human esophageal cancers. [6] [7] [8] Therefore, this model is a valuable tool to investigate novel approaches to manage Barrett's esophagus and esophageal cancer.
Within the context of cancer, prostaglandin E2 (PGE2) generally is considered to possess potent tumor-promoting activity. PGE2 suppresses the cytotoxicity and cytokine production of natural killer cells. Furthermore, the polarization of tumor-associated macrophages (TAMs) toward tumor-promoting M2 macrophages also is influenced by PGE2 in lung carcinoma cells. 9 Thus, PGE2 exerts diverse effects on tumor microenvironment such as cell proliferation, inflammation, and immune surveillance. 10 In vitro, gastroesophageal reflux (GER) contents induce PGE2 production, which is produced by cyclooxygenase-2 (COX-2), in esophageal cancer cells. 11 Furthermore, bile acid progressively induced COX-2 expression in a dose dependent manner in esophageal cancer cells. 12 In our previous animal study, we found that increased severe duodenal content reflux including bile acid promoted the development of EADC, while rodents subjected to mild duodenal content reflux were more likely to develop ESCC. 13 Thus, the severity of duodenal reflux is related to the development of different histological types of esophageal cancer.
Traditional herbal medicine (Kampo medicine) has a long and rich history in Japan and is used concurrently with modern medicine to this day. 14 Hangeshashinto (TJ-14) is a traditional Japanese medicine containing 7 herbal components. TJ-14 is prescribed in Japan to treat inflammatory diarrhea, gastritis, and stomatitis. 15 TJ-14 has been reported previously as an effective oral mouthwash for the treatment of chemotherapy-induced oral mucositis. 16 In pilot studies, TJ-14 was demonstrated to inhibit PGE2 production 17 and reduce PGE2 contents in human oral keratinocytes cell lines. 18 TJ-14 also has been shown to inhibit COX-2 activity in vivo and animal models. [17] [18] [19] We explored the use of TJ-14 as a chemoprevention agent in a surgical rat reflux model of esophageal carcinogenesis with the goal of altering the tolerogenic tumor microenvironment. The aim of the present study was to assess the incidence of esophageal cancer and the infiltration of M2 macrophages in rats surgically prepared to reflux gastroduodenal contents. Furthermore, we evaluate the PGE2 production by bile acid or GER content exposure in ESCC cell.
Materials and Methods
The Institutional Animal Care and Use Committee of the Graduate School of Medical Science, Kanazawa University approved this study.
Experimental animals
Thirty male Wistar rats, weighing ≈250 g, were used in the study. We set the group size at 15 rats based on prior experience with this model. 20 The animals were housed 3 per cage and maintained at a constant room temperature of 22 ± 3 °C and 55 ± 5% humidity with a 12-hour light-dark cycle. These were randomly divided into 2 groups: the control group, consisting of 12 rats, was given standard solid chow CRF-1 (Charles River, Japan); the TJ-14 group, consisting of 10 rats, was given experimental solid chow premixed with Hangeshashinto (TJ-14; 3.0 g/kg body) without carcinogen.
Surgical procedure
After a 24-hour fast, an upper abdominal incision was made under diethyl-ether inhalation anesthesia. Briefly, the esophagus was mobilized, preserving the vagus nerves and vasculature of the neck. A loop of jejunum was then identified 4 cm from the ligament of Trietz. The gastroesophageal junction was ligated and an end-to-side anastomosis was constructed between the distal esophagus and jejunum, as previously reported. [20] [21] [22] 
Specimen extraction
The animals were killed by diethyl-ether inhalation, after which the abdomen was opened. A ligature was placed around the afferent and efferent jejunal loop near the esophago-jejunal anastomosis. The esophagus was ligated at the level of the thyroid cartilage through a thoracotomy. The esophagus and the anastomosed jejunum then were removed.
Pathologic assessment
Excised organs were washed with 10% formalin, spread, and pinned on a cork plate with the mucosal side up. After fixing the organs with 10% formalin solution for at least 24 hours, the esophagus was cut along the longitudinal axis into slices at 3-mm intervals and embedded in paraffin. In addition, 5 μm thick sections of each embedded paraffin block were prepared for histologic analysis with hematoxylin and eosin (H&E) stain. The pathologic and histologic assessment were performed in a blinded fashion by a pathologist.
Immunohistochemistry
For immunohistochemical staining, the Dako Envision system, which uses dextran polymers conjugated with horseradish peroxidase (Dako, Carpinteria, CA), was used to avoid any endogenous biotin contamination. The sections were deparaffinized in xylene and rehydrated in a graded ethanol series. Endogenous peroxidase was blocked by immersing the sections in 3% H 2 O 2 in 100% methanol for 20 minutes at room temperature. Antigen retrieval was achieved by microwaving sections at 95 °C for 10 minutes in 0.001 M citrate buffer (pH 6.7). After blocking the endogenous peroxidase, the sections were incubated with Protein Block Serum-Free (Dako) at room temperature for 10 minutes to block nonspecific staining. The sections then were incubated for 2 hours at room temperature with 1:100 diluted mouse monoclonal antibody against CD163 (anti-CD163 mouse monoclonal, ED2; AbD serotec). Peroxidase activity was detected with the enzyme substrate 3-amino-9-ethyl carbazole. For the negative controls, the sections were incubated with Tris-buffered saline without the primary antibodies. Samples in which at least 10% of tumor cells were slightly counterstained with Meyer hematoxylin were defined as showing positive staining. Immunohistochemical staining for CD163 was scored by 2 of the authors K.M. and D.M. as positive or negative in the epithelium under study. An estimation of the immunohistochemical expression of the markers was made by counting at least 100 cells in random high-power fields. Results were expressed as the total number of positive cells/total number of cells ×100.
Definition of pathologic findings
Histologic findings in the esophagus were classified into the following 4 categories:
Proliferative squamous hyperplasia (PHP): Proliferative hyper-
plasia is a condition characterized by a thickened epithelium to twice that of a normal epithelium with acanthosis, elongation of the papillae, and parakeratosis. Other features include the thickening of the basal layer of the squamous epithelium and the preservation of a stratified appearance. 2. Squamous dysplasia: Here the epithelium is composed of dysplastic squamous cells with large and polymorphic nuclei with deeply stained chromatin and increased number of mitotic figures. Squamous dysplasia may involve lamina propria of the epithelium but does not invade the submucosal layer. 3. Barrett's metaplasia (BM): Replacement of esophageal squamous epithelium with columnar-lined epithelium, comprised of gastric and/or intestinal cells. 4. Carcinoma: Carcinoma is defined as cellular and structural atypism with epithelial invasion into the submucosal layer. Adenocarcinoma (ADC) consists of dysplastic glandular cell growth with both atypia and invasiveness and has 2 types of histology: tubular or papillary ADC, and mucinous ADC. Squamous cell carcinoma (SCC) is a type of squamous cell dysplasia with marked cellular and structural atypism. This carcinoma may be divided into well-differentiated and poorly differentiated types according to the presence or absence of cancer pearls, respectively.
Reagents
TJ-14 is an aqueous extract containing a mixture of 7 crude drugs: Pinelliae tuber (Pinellia tuber), Scutellariae radix (Scutellaria root), Glycyrrhizae radix (Glycyrrhiza), Zizyphi fructus (jujube), Ginseng radix (ginseng), Zingiberis processum rhizoma (processed ginger), and Coptidis rhizoma (Coptis rhizome). The dried, powdered form of TJ-14 (Lot No. 342213700) was obtained from Tsumura & Co. (Tokyo, Japan). TJ-14 was suspended in phosphatebuffered saline at 100 mg/mL for performing an in vitro assay.
Cell culture
Human esophageal squamous cell carcinoma KYSE-270 cells (ECACC, Salisbury, UK) were cultured in F12/RPMI-1640 medium (1:1, pH 7.2) supplemented with 100 units/mL penicillin G and 0.1 mg/mL streptomycin containing 2% fetal bovine serum and 2 mM glutamine at 37 °C and 5% CO 2 conditions.
Cell treatment
Cells were seeded in 96-well plates and incubated overnight. After replacing the culture fluids with the same fresh medium with pH 7.2, the cells were treated for 2 hours with vehicle (0.1% dimethyl sulfoxide), the bile acid chenodeoxycholic acid (CDCA; 200 or 400 μmol/L; Wako Chemical, Osaka, Japan), or GER contents 11 ; 200 μmol/L CDCA and 0.001% trypsin in a medium with pH 6.5. The cells were then washed and cultured in a fresh medium with pH 7.2 for an additional 6 hours. Vehicle (phosphate-buffered saline) or TJ-14 (1, 10, and 100 μg/mL) was treated for 8 hours in a row. Finally, the culture medium was collected for performing PGE2 enzyme immunoassay and lactate dehydrogenase (LDH) assay.
PGE2 estimation
PGE2 in the culture medium was quantified using a PGE2 enzyme immunoassay kit (Cayman Chemical Co., Ann Arbor, MI).
LDH assay
LDH assay was performed using a LDH-Cytotoxic Test kit (Wako Chemical, Osaka, Japan). Cell viability was calculated using the formula for relative LDH activity and was compared with the maximum value generated using 0. 
Statistical analysis
All quantitative studies were expressed as the mean ± standard error (SE). Differences were analyzed for significance using Student t test, Mann-Whitney rank-sum test, χ 2 test, Fisher exact test, or Dunnett's multiple comparison test, as appropriate. Data management and statistical analysis were performed using Stat View software (SAS Co., Berkeley, CA).
Results

Rat surgical reflux model
Of the 30 operated animals, 22 rats survived 40 weeks postsurgery and were included in the study. Of these, 12 were part of the placebo group, while the remaining 10 were placed in a TJ-14 group. A total of 8 rats (3 in the placebo group and 5 in the TJ-14 group) died of surgical complications, such as malnutrition, pneumonia, and unknown causes.
No differences in mortality were noted between the 2 groups. Body weight did not differ between the 2 groups ( Table ) .
Macroscopic
In the placebo group, the middle to distal portions of the esophagus were thickened in all rats and the epithelia were irregular ( Fig 1, A ) . In contrast, the rats in the TJ-14 group displayed smooth distal portions of the esophagus with normal width ( Fig 1, B ) . The incidence of * cancer ( P < .05, χ 2 ) and † Barrett's Metaplasia ( P < .1, χ
2 ) was lower in the TJ-14 group, compared to the placebo group. ‡ Three animals developed both squamous cell carcinoma and adenocarcinoma.
Microscopic
While 67% (8/12) of animals in the placebo group developed esophageal cancer, animals in the TJ-14 group had an incidence of cancer of 10% (1/10). Animals in the TJ-14 group were associated with a lower incidence of cancer development compared to the placebo group ( P = . 007, χ 2 ; Table ) . In the placebo group, 8 rats displayed ADC ( Fig 2, A ) and 3 rats developed SCC ( Fig 2, B ) , while one rat in the TJ-14 group developed SCC. BM ( Fig 2, C ) was found on 83% (10/12) of the rats in the placebo group, but there was a protective tendency in the TJ-14 group with 50% (5/10) of the rats displaying signs of BM ( P = . 095, χ 2 ; Table ) . All of the rats in the TJ-14 and placebo groups developed PHP ( Fig 2, D ) .
CD163 expression
CD163 positive macrophages infiltrated into the ADC ( Fig 2, E ) , SCC ( Fig 2, F ), BM ( Fig 2, G ) , and PHP ( Fig 2, H ) in the placebo group. However, CD163 positive macrophages decreased in the TJ-14 group compared to the placebo control group in BM ( P = . 0 0 01) and carcinoma lesion ( P = . 055; Fig 3 ) . There were no differences between ADC and SCC with respect to CD163 positive macrophages ( P = . 247, Mann-Whitney U test).
PGE2 production in the esophageal squamous cell carcinoma KYSE-270 cells
Treatment with CDCA (200 or 400 μmol/L) or GER contents significantly increased PGE2 production in KYSE-270 cells compared with vehicle treatment (Vehicle; 42.5 ± 2.1, CDCA [200 μmol/L]; 60.9 ± 3.6, P = .013, CDCA [400 μmol/L]; 100.7 ± 4.4, P = .0000078, GER contents; 119.4 ± 3.2, P = .0 0 0 0 028; Fig 4, A ) . Treatment with CDCA or GER contents had little effect on cell viability ( Fig 4, B ) . Fig 4, C ) . It also inhibited GER content-induced PGE2 production (Vehicle; 167.6 ± 3.1, TJ-14 [1 μg/mL]; 141.9 ± 1.5, P = . 026, TJ-14 [10 μg/mL]; 128.9 ± 11.1, P = . 0 033, TJ-14 [10 0 μg/mL]; 72.1 ± 5.0, P = . 0 0 0 0 091; Fig 4, C ) . No cytotoxic effects of TJ-14 on KYSE-270 cells were observed even at the 100 μg/mL TJ-14 ( Fig 4, D ) .
Discussion
We addressed the hypothesis that the TJ-14 could reduce the incidence of cancer and the infiltration of M2 macrophage in a rodent model of surgically induced gastroduodenal esophageal reflux or could suppress PGE2 production by bile acid or GER content exposure in ESCC cell.
Chronic inflammation has been identified as a major risk factor for carcinogenesis in the gastrointestinal tract including esophageal cancer. Our longstanding rat surgical model of EADC development involves the exposure of the distal esophageal epithelium to caus-tic gastric and bile acids through reflux (GERD), which triggers chronic inflammation and the development of BM, the precursor lesion to EADC. 7 We have established that the progression to EADC is sequential, beginning with duodeno-gastro-esophageal reflux to the development of inflammation-induced squamous hyperplasia and metaplasia, such as BM. This is followed by multifocal EADC. 23 Through cytogenetic and karyotype analyses, tumor cells harvested from rats subjected to the surgical reflux model were found to share common morphologies, mucin features, pathways, and the expression of differentiation markers with human esophageal cancer. 8 Regarding esophageal carcinogenesis, there is accumulating evidence that a comprehensive understanding of the molecular composition of esophageal cancer requires attention to not only tumor cells, but also the tumor microenvironment. This tumor microenvironment contains diverse cell populations, signaling factors, and structural molecules that interact with tumor cells and support all stages of tumorigenesis. 24 Antitumor immunity, attenuated by cell populations such as TAMs, can have other protumorigenic functions. These include the induction of angiogenesis, tumor cell invasion, 25 myeloid-derived suppressor cells, and regulatory T (Treg) cells. Macrophages are polarized to either the classical M1 type or alternative M2 type, unlike TAMs which are polarized to M2 or M2-like types. 26 In our prior study, we demonstrated that M1 phenotype macrophages infiltrate the esophagus and activate the Stat3 pathway in stromal cells and epithelium at an early stage in reflux esophagitis using this rat model. M2 phenotype macrophage TAMs infiltrate after infiltration of M1 macrophages and contribute to tumor development along with Tregs. Thus, the inflammatory tumor microenvironment is critical in esophageal carcinogenesis. 27 These recent findings make a compelling case for targeting the tumor microenvironment for cancer chemoprevention. 28 It is widely accepted that alterations to COX-2 expression, which is a rate-limiting enzyme for prostanoid biosynthesis, and the abundance of its enzymatic product PGE2 have key roles in influencing the development of cancer. 29 Induction of the COX-2/PGE2 pathway in tumor stroma is important for the development and maintenance of an inflammatory microenvironment in gastrointestinal tumors. 30 COX-2/PGE2 play a key role in generation of the inflammatory microenvironment in tumor tissues. Several reports have shown that PGE2 promotes the tumor growth by stimulating angiogenesis, cell invasion, cell growth and survival. 31, 32 PGE2 has been found to promote M2 macrophage polarization in part via induction of the cyclic AMP (cAMP) pathway. The cAMP-responsive element binding (CREB) pathway seems to block M1 macrophage function in part via the induction of the anti-inflammatory cytokine IL-10. 33,34 PGE2 was responsible for the conversion of monocytes to M2 macrophages. 35 The M2 differentiation was induced by tumor-produced PGE2 and IL-6, facilitating a tolerogenic tumor microenvironment. 35 The COX-2/PGE2 pathwayinduced inflammatory network is important for the education of macrophages into the protumorigenic M2 or M2-like types. 30 It is necessary to develop new insights into the pathophysiology of the tumor microenvironment to develop new approach for local control.
The role of bile acid in promoting carcinogenesis of the digestive tract has been demonstrated both clinically and experimentally. 6, 36 Recently, one of the molecular targets of bile acid has been revealed to be COX-2, which is involved in various biological phenomena, such as apoptosis, proliferation and differentiation, and angiogenesis. The bile acid, CDCA, progressively induced COX-2 expression in a dose dependent manner. 12 Thus, many experimental studies using cell lines and animal models have demonstrated an ability of COX-2 inhibitor to prevent tumor proliferation. 37, 38 We did not directly measure COX-2 expression in this study. In our previous study, the COX-2 inhibitor celecoxib was effective in preventing BE and EADC by suppressing esophagitis in the same rat model. The COX-2 inhibitor group did not suppress COX-2 mRNA expression, but suppressed PGE2 induction compared to control group. 39 The use of a COX-2 inhibitor clinically is US Food & Drug Administration approved in the United States. After a randomized study in 20 0 0 showed that the treatment with celecoxib significantly reduced the number of colorectal polyps in patients with familial adenomatous polyposis, the US Food & Drug Administration approved the clinical use of celecoxib for familial adenomatous polyposis patients. Enthusiasm for the use of celecoxib has been tempered by recent reports that some COX-2 inhibitors increase the risk of serious cardiovascular events including heart attack and stroke. 40 It is necessary to find complementary or alternative treatments for chemoprevention in esophageal carcinogenesis.
TJ-14 is a pharmaceutical formulation with ingredients active in the COX pathway, including Pinelliae tuber, Scutellariae Radix, Glycyrrhizae Radix, Zizyphi Fructus, Ginseng Radix, Zingiberis Processum rhizoma, and Coptidis rhizome. 16, 41 In particular, baicalin, baicalein, and wogonin, compounds found in Scutellariae Radix play primary roles in the inhibition of both COX2 activity and production of PGE 2 . 42 Glycyrrhizin in Glycyrrhizae Radix and ginsenosides in Ginseng Radix also suppress COX activity by inducing corticosterone secretion. 17 We also reported that inducible PGE2, PGD2, and PGF2 α, metabolites of COX pathways, were reduced by TJ-14 without inducing cytotoxicity using human oral keratinocytes (HOK). The [6] -shogaol, [6] -gingerol, wogonin, baicalein, baicalin, and berberine, active ingredients of TJ-14, were shown to reduce PGE2 production. A mixture of these 6 ingredients at concentrations equal to 300 μg/mL of TJ-14 strongly suppressed PGE2 production to the same level as TJ-14.
[6]-Shogaol and [6]-gingerol did not decrease COX-2 mRNA expression and mostly inhibited PGE2 metabolic activity in an assay using intact HOK cells, suggesting that they regulate PGE2 synthesis at the posttranscriptional level. Wogonin, baicalin, and berberine inhibited expression of COX-2 mRNA without affecting PGE2 metabolic activity. Moreover, wogonin, but not [6] -shogaol, suppressed phosphorylation of mitogenactivated protein kinases (p38s and JNKs). 18 It has been reported that the activity of COX-1 was not inhibited by TJ-14 orally administered to rats, while COX-2 was inhibited in a dose-dependent manner. 17 Kamide et al also reported that TJ-14 exerted a preventative effect against radiation-induced mucositis by inhibiting the expression of COX2 and inflammatory cell chemotaxis via its antimicrobial activity. 19 Moreover, TJ-14 demonstrated a significant effect in the treatment of over grade 2 oral mucositis induced by chemotherapy in patients with colorectal cancer compared to the placebo. 43, 44 In the present study, TJ-14 inhibited CDCA or GER content-induced PGE2 production in esophageal cell. Furthermore, TJ-14 had no cytotoxic effects on esophageal cell. Also, cardiac toxicity as well as other severe adverse effects from TJ-14 was not observed in human trials. 43, 44 Our data showed that M2 phenotype macrophage levels were decreased in the TJ-14 group compared to the control group. TJ-14 may have suppressed inducible M2 phenotype macrophage levels via its ability to reduce the PGE2 product of COX2.
Given those biochemical and in vivo study findings raised the hypothesis: TJ-14 is advantageous because it is safe, easily applied, and preventive efficacious for esophageal carcinogenesis by changing the tolerogenic tumor microenvironment.
In conclusion, TJ-14 protected against the development of esophageal cancer by alternation of the tumor microenvironment in a clinically relevant surgical reflux model. TJ-14 also inhibited GER content, including bile acid-induced PGE2 production in esophageal cancer cell. Further investigation is required regarding the potential clinical use of TJ-14 as a chemopreventive agent in patients with, or at risk for, esophageal ADC.
